Rare diseases
Investigational molecules
Locations
4850 West 78th Street, 46268-2385, United States
Clinical research is centered on metastatic castration-resistant prostate cancer, with interest in patients whose disease has progressed after androgen receptor axis-targeted therapy. The trial activity reflects a focus on advanced oncology care in the setting of treatment-resistant disease.
The research landscape is concentrated on treatment options for men with progressive disease after hormonal therapy, with attention to radiographic progression in advanced prostate cancer.
Point Biopharma Inc. runs clinical trials in conditions such as Hormone-refractory prostate cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
